Abstract
Despite the introduction of IRAS, obtaining R&D approvals for multicentre studies is a major rate limiting step. Our experience with cleft research demonstrates that this approvals process must be drastically and rapidly improved if we wish to continue attract clinical research to the UK.
| Original language | English |
|---|---|
| Pages (from-to) | 59-61 |
| Number of pages | 2 |
| Journal | British Dental Journal |
| Volume | 211 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2011 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Swedish Standard Keywords
- Public Health, Global Health and Social Medicine (30311)
Fingerprint
Dive into the research topics of 'Why are multi-centre clinical observational studies still so difficult to run?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver